Dr Andrew Rut: Opportunities and challenges for drug safety in Japan


The Japanese pharmaceuticals market has undergone significant shakeup in recent years, now reaching new leagues as the third biggest pharmaceuticals market in the world.

In a recent article with Pharma Business International, Dr Andrew Rut, CEO and co-founder of MyMeds&Me, discusses the opportunities and challenges of drug safety in Japan in the face of market growth and regulatory change.

Read the article here

Request More Information

To find out more or request a demo fill in the details below:

By submitting your information, you are consenting to receive communications from MyMeds&Me. You may at any time 'opt out' of receiving these marketing communications by emailing info@mymedsandme.com.


We use analytical cookies that need your permission. For more details and advanced options view our Cookies Policy.